GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LifeTech Scientific Corp (STU:81X) » Definitions » ROE % Adjusted to Book Value

LifeTech Scientific (STU:81X) ROE % Adjusted to Book Value : 7.56% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is LifeTech Scientific ROE % Adjusted to Book Value?

LifeTech Scientific's ROE % for the quarter that ended in Jun. 2024 was 12.09%. LifeTech Scientific's PB Ratio for the quarter that ended in Jun. 2024 was 1.60. LifeTech Scientific's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was 7.56%.


LifeTech Scientific ROE % Adjusted to Book Value Historical Data

The historical data trend for LifeTech Scientific's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeTech Scientific ROE % Adjusted to Book Value Chart

LifeTech Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 2.46 3.37 3.07

LifeTech Scientific Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.16 2.23 4.12 0.97 7.56

Competitive Comparison of LifeTech Scientific's ROE % Adjusted to Book Value

For the Medical Devices subindustry, LifeTech Scientific's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeTech Scientific's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LifeTech Scientific's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where LifeTech Scientific's ROE % Adjusted to Book Value falls into.



LifeTech Scientific ROE % Adjusted to Book Value Calculation

LifeTech Scientific's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.19% / 2.67
=3.07%

LifeTech Scientific's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=12.09% / 1.60
=7.56%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LifeTech Scientific ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of LifeTech Scientific's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeTech Scientific Business Description

Traded in Other Exchanges
Address
No. 22, Keji 12th Road South, LifeTech Scientific Building, High-tech Industrial Park, Nanshan District, Shenzhen, CHN, 518063
LifeTech Scientific Corp develops and manufactures also responsible for marketing of of advanced minimally invasive interventional medical devices for cardiovascular and peripheral vascular diseases and disorders. The firm operates in three areas: Structural heart diseases business; Peripheral vascular diseases business and Cardiac pacing and electrophysiology business. It generates maximum revenue from the Peripheral vascular diseases business segment. Geographically, it derives a majority of revenue from China.

LifeTech Scientific Headlines

No Headlines